Biotech’s new company model; The super poop behind a startup launch; and morenews2026-05-09T10:00:14+00:00May 9th, 2026|Endpoints News|
Trump plans to fire Makary from FDA role, according to reportsnews2026-05-08T17:32:09+00:00May 8th, 2026|Endpoints News|
Daiichi Sankyo posts ‘extraordinary loss’ of nearly $1Bnews2026-05-08T17:16:32+00:00May 8th, 2026|Endpoints News|
FDA delays Leqembi decision; Artiva raises $300M; Pharvaris prices offeringnews2026-05-08T15:09:06+00:00May 8th, 2026|Endpoints News|
‘Pharma, not really’: Top young AI talent shuns careers at big drugmakersnews2026-05-08T13:09:49+00:00May 8th, 2026|Endpoints News|
Natalie Holles’ next move after Third Harmonic shutdown; Mark Alles passes the torch at ADC biotechnews2026-05-08T11:00:32+00:00May 8th, 2026|Endpoints News|
Capricor sues Nippon Shinyaku over Duchenne drug ‘pricing flaw’ and launch prepnews2026-05-08T11:00:19+00:00May 8th, 2026|Endpoints News|
Odyssey raises more than $300M as biotech goes public in IPOnews2026-05-08T01:44:43+00:00May 8th, 2026|Endpoints News|
Astellas touts data from early test of stem cell-derived eye therapynews2026-05-07T22:13:30+00:00May 7th, 2026|Endpoints News|
Amazon adds Ozempic pill to same-day prescription drug kiosksnews2026-05-07T17:15:46+00:00May 7th, 2026|Endpoints News|
